Government’s plan to allow exclusive sales of pregnancy reagents by medical device vendors stirs deb

Published: 2013-09-04 06:57:00

Updated: 2013-09-04 06:57:00

The Ministry of Food and Drug Safety (MFDS)’s plan, under which medical device vendors are allowed to exclusively market pregnancy tester other than pharmacies or drug wholesalers, is mired in controversy as questions grow about its feasibility.

The ministry said that the exclusive sales of in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK